Protego wound dressing gets US FDA approvalDecember 6, 2019
The US FDA cleared Protego antimicrobial wound dressing, Turn Therapeutics announced.
Protego wound dressings are single-use, sterile, antimicrobial gauze dressings impregnated with Hexagen, a petrolatum-based wound care emulsion built on the company’s proprietary PermaFusion technology.
Protego, with Hexagen built in, offers clinicians the same gentleness, feel, and utility as traditional, petroleum saturated gauze dressings, but with the added benefit of broad-spectrum antimicrobial protection against bacteria, fungi, and yeasts.
PermaFusion is a first of its kind, petrolatum-based, liquid-in-oil suspension technology that literally fuses liquid and oil.
Active ingredients are permanently suspended in the liquid nanodroplets with an average size of 1.3 micron within the lipid carrier. PermaFusion enables maximum bioavailability, yet at minimal concentration.